|
|
Nutri Pharma ASA - Comparative Business Analysis Snapshot
Business Description
Nutri Pharma ASA. The Group's principal activity is to develop products that beneficially influence lifestyle related disorders. The lifestyle related diseases are obesity, hyperlipidaemia and type 2 diabetes. The Group develops a range of products based on soy ingredients, using isolated soy protein with high levels of isoflavones and cotyledon soy fibre. The soy technology prevents the development of life style related diseases such as obesity, elevated cholesterol levels and type 2 diabetes. The Group operates in two segments: Royalty and Direct Sales. Products include Nutrilett (weight management), Abacor (cholesterol reduction) and Abalon (for diabetes treatment).
Competitor Analysis
This analysis compares Nutri Pharma ASA with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
